Advertisement
Advertisement
U.S. markets open in 7 hours 53 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Stayble Therapeutics AB (4K4.SG)

Stuttgart - Stuttgart Delayed Price. Currency in EUR
0.3350-0.0130 (-3.74%)
At close: 03:44PM CET
Advertisement
Advertisement
Show:
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Breakdown
ttm
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Total Revenue
0
0
0
0
0
Operating Expense
24,767
12,140
14,984
6,872
6,120
Operating Income
-24,767
-12,140
-14,984
-6,872
-6,119
Net Non Operating Interest Income Expense
163.929
-28.071
-396.168
-533.349
-14.8
Pretax Income
-24,526
-12,090
-15,487
-7,408
-6,134
Tax Provision
-
-
-
-
0
Net Income Common Stockholders
-24,526
-12,090
-15,487
-7,408
-6,134
Diluted NI Available to Com Stockholders
-24,526
-12,090
-15,487
-7,408
-6,134
Basic EPS
-
-0.87
-1.78
-0.85
-0.71
Diluted EPS
-
-0.87
-1.78
-0.85
-0.71
Basic Average Shares
-
13,847
8,687
8,678
8,678
Diluted Average Shares
-
13,847
8,687
8,678
8,678
Total Operating Income as Reported
-24,769
-12,140
-14,925
-6,875
-6,119
Total Expenses
24,767
12,140
14,984
6,872
6,120
Net Income from Continuing & Discontinued Operation
-24,526
-12,090
-15,487
-7,408
-6,134
Normalized Income
-24,526
-12,090
-15,487
-7,408
-6,134
Interest Income
523.019
29.019
0
1.522
0
Interest Expense
359.09
57.09
396.168
534.871
14.8
Net Interest Income
163.929
-28.071
-396.168
-533.349
-14.8
EBIT
-24,167
-12,033
-15,091
-6,873
-6,119
EBITDA
-24,167
-
-
-
-
Net Income from Continuing Operation Net Minority Interest
-24,526
-12,090
-15,487
-7,408
-6,134
Normalized EBITDA
-24,167
-12,033
-15,091
-6,873
-6,119
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
Advertisement
Advertisement